Colgate-Palmolive (NYSE:CL) VP Philip G. Shotts sold 8,800 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $71.66, for a total value of $630,608.00. Following the completion of the sale, the vice president now directly owns 50,032 shares in the company, valued at approximately $3,585,293.12. The transaction was disclosed in a document filed with the SEC, which is available through this link.
Shares of NYSE CL opened at $71.97 on Friday. The company has a current ratio of 1.07, a quick ratio of 0.74 and a debt-to-equity ratio of 32.25. Colgate-Palmolive has a fifty-two week low of $57.41 and a fifty-two week high of $73.10. The stock has a market cap of $61.79 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 4.72 and a beta of 0.81.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.66 by $0.01. Colgate-Palmolive had a negative return on equity of 3,730.37% and a net margin of 15.08%. The business had revenue of $3.88 billion for the quarter, compared to analyst estimates of $3.86 billion. During the same quarter last year, the company earned $0.74 EPS. The business’s quarterly revenue was down 2.9% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 2.83 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were given a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 2.39%. The ex-dividend date of this dividend was Wednesday, April 17th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.91%.
A number of research firms have issued reports on CL. ValuEngine raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Monday, May 13th. Macquarie increased their price target on Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a research report on Monday, April 29th. Morgan Stanley increased their price target on Colgate-Palmolive from $62.00 to $68.00 and gave the company an “equal weight” rating in a research report on Monday, April 29th. Finally, Jefferies Financial Group increased their price target on Colgate-Palmolive from $61.00 to $73.00 and gave the company an “in-line” rating in a research report on Monday, April 29th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and five have given a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $69.69.
Several hedge funds and other institutional investors have recently modified their holdings of CL. Vanguard Group Inc increased its position in Colgate-Palmolive by 1.0% during the third quarter. Vanguard Group Inc now owns 73,520,894 shares of the company’s stock worth $4,922,224,000 after buying an additional 734,860 shares during the period. Stock Yards Bank & Trust Co. increased its position in Colgate-Palmolive by 3.3% during the fourth quarter. Stock Yards Bank & Trust Co. now owns 9,388 shares of the company’s stock worth $558,000 after buying an additional 300 shares during the period. McCollum Christoferson Group LLC increased its position in Colgate-Palmolive by 1.2% during the fourth quarter. McCollum Christoferson Group LLC now owns 76,720 shares of the company’s stock worth $4,566,000 after buying an additional 929 shares during the period. Investment Partners LTD. acquired a new position in Colgate-Palmolive during the fourth quarter worth approximately $341,000. Finally, Rockland Trust Co. increased its position in Colgate-Palmolive by 4,070.6% during the fourth quarter. Rockland Trust Co. now owns 144,093 shares of the company’s stock worth $8,577,000 after buying an additional 140,638 shares during the period. 75.95% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
See Also: Reverse Stock Split
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.